Changes

no edit summary
Line 7: Line 7:  
!Notes
 
!Notes
 
|-
 
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
+
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera
 +
|Fabiola Quintero-Rivera (FQR)
 
|
 
|
 
|
 
|
Line 84: Line 85:  
|
 
|
 
|-
 
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
+
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 +
|FQR
 
|
 
|
 
|
 
|
Line 107: Line 109:  
|
 
|
 
|-
 
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Sarah Rapisardo
+
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Daynna J.Wolff
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING